Altre lingue Opyl Limited Australian S.E.

Azioni

Prezzo di chiusura Australian S.E. Altri mercati azionari			Variaz. 5gg	Var. 1 gen.
- ^AUD	-.--%		-.--%	-.--%

20/03	Opyl richiede una sospensione delle negoziazioni dopo aver ricevuto un'offerta per l'attività Opin	MT
15/03	Il presidente di Opyl si dimette a fine aprile	MT

Opyl Expands TrialKey Coverage; Shares Up 38%	29/04
Opyl to Divest Opin Business	23/04
Opyl Receives Offer for Patient Recruitment Business	22/03
Trial Screen Pty Ltd entered into a non-binding offer to acquire Opin business from Opyl Limited.	22/03
Opyl Requests Trading Halt After Receiving Offer For Opin Business	20/03
Opyl Chair Stepping Down in End-April	15/03
Opyl Limited Reports Earnings Results for the Half Year Ended December 31, 2023	28/02
Opyl Raises Nearly AU$900,000 from Rights Issue Shortfall Placement	09/02
Opyl Grows Cash Receipts for Fiscal Q2	31/01
Opyl Receives Commitments for Potential Shortfall	02/01
Opyl Appoints Interim CEO	24/11
Opyl Limited Appoints Saurabh Jain as Interim Chief Executive Officer	23/11
Opyl Secures R&D Tax Rebate for Fiscal Year 2023	22/09/23
Opyl Limited Announces Appointment of Antanas Guoga as Director, Effective from September 4, 2023	05/09/23
Opyl Limited Announces Board Update	04/09/23
Opyl Limited Reports Earnings Results for the Full Year Ended June 30, 2023	30/08/23
Opyl Limited Launches TrialKey MVP	24/08/23
Opyl Limited Announces Senior Leadership Changes	05/07/23
Opyl Limited Announces Resignation of Michelle Gallaher as CEO	05/07/23
Opyl Limited Appoints Dr. Hugo Stephenson as Board Advisor	02/05/23

Non ci sono risultati per questa ricerca